Log in
Enquire now
Theraclone Sciences

Theraclone Sciences

A biotechnology company that develops therapeutic antibodies for treating infectious diseases and inflammation

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
AngelList URL
angel.co/theraclone-sciences
B2X
B2B
B2B
0
CEO
‌
Clifford J. Stocks
0
CFO
‌
Chris Russell
0
Legal Name
Theraclone Sciences, Inc.
Company Operating Status
Active
Country
United States
United States
0
Crunchbase URL
crunchbase.com/organiz...sciences
Email Address
info@oncoresponse.com
0
Fax Number
206-805-1699
0
Full Address
1124 Columbia Street Suite 300 Seattle, WA 98104
0
Industry
Immunotherapy
Immunotherapy
0
Healthcare
Healthcare
Biopharmaceutical
Biopharmaceutical
Technology
Technology
Biology
Biology
Biotechnology
Biotechnology
Investors
Alexandria Real Estate Equities
Alexandria Real Estate Equities
Canaan
Canaan
Amgen Ventures
Amgen Ventures
HealthCare Ventures
HealthCare Ventures
ARCH Venture Partners
ARCH Venture Partners
MPM Capital
MPM Capital
Zenyaku Kogyo (pharmaceutical company)
Zenyaku Kogyo (pharmaceutical company)
Latest Funding Round Date
November 8, 2011
Latest Funding Type
Series B
Series B
Location
Seattle
Seattle
0
Patents Assigned (Count)
14
Phone Number
+12068051600
0
Pitchbook URL
pitchbook.com/profiles.../52749-46
Total Funding Amount (USD)
54,084,603
Official Website
theraclone-sciences.com
oncoresponse.com
Wellfound ID
theraclone-sciences

Find more companies like Theraclone Sciences

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.